Method for reducing cholesterol by co-administering M-CSF and conventional cholesterol reducing agents
US5340573A · kind A · utility
1Cited by
0References
4Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Mar 8, 1993 |
| Grant date | Aug 23, 1994 |
| Priority date | — |
| Expiry date | Mar 8, 2013 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/785
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods are presented for improving the lipoprotein cholesterol profile of a mammal. Methods are also presented for removing atherosclerotic lesions from a mammal that has such lesions. The methods comprise administering to the mammal a therapeutic amount of an M-CSF protein in combination with a pharmaceutically acceptable excipient.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.